These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4148450)

  • 21. Effect of structural modification of the hydantoin ring on anticonvulsant activity.
    Cortes S; Liao ZK; Watson D; Kohn H
    J Med Chem; 1985 May; 28(5):601-6. PubMed ID: 3989820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanochemical preparation of hydantoins from amino esters: application to the synthesis of the antiepileptic drug phenytoin.
    Konnert L; Reneaud B; de Figueiredo RM; Campagne JM; Lamaty F; Martinez J; Colacino E
    J Org Chem; 2014 Nov; 79(21):10132-42. PubMed ID: 25279490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANTIEPILEPTIC DRUGS.
    LIVINGSTON S
    Am J Nurs; 1963 Oct; 63():103-7. PubMed ID: 14045202
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
    Kamiński K; Rzepka S; Obniska J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturates.
    Roeda D; Westera G
    Int J Appl Radiat Isot; 1981 Nov; 32(11):843-5. PubMed ID: 7309275
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V.
    Kamiński K; Obniska J; Chlebek I; Liana P; Pękala E
    Eur J Med Chem; 2013 Aug; 66():12-21. PubMed ID: 23777899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and anticonvulsant activity of new N-Mannich bases derived from spirosuccinimides and spirohydantoins.
    Obniska J; Byrtus H; Kamiński K; Pawłowski M; Szczesio M; Karolak-Wojciechowska J
    Bioorg Med Chem; 2010 Aug; 18(16):6134-42. PubMed ID: 20638856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis of benzylidene derivatives of 3-O-chlorophenyl-2-thiohydantoin and the study of their anticonvulsive properties].
    Rydzik E; Szadowska A; Kamińska A
    Acta Pol Pharm; 1979; 36(2):167-72. PubMed ID: 532678
    [No Abstract]   [Full Text] [Related]  

  • 29. [Correlation between brain electric activity and overdose of anticonvulsants].
    Müller J; Müller D
    Nervenarzt; 1972 May; 43(5):270-2. PubMed ID: 5052674
    [No Abstract]   [Full Text] [Related]  

  • 30. Naloxone-6-spirohydantoin: a new non-toxic compound with anticonvulsive properties.
    Chatterjie N; Alexander GJ
    Neuropharmacology; 1983 Sep; 22(9):1151-3. PubMed ID: 6633824
    [No Abstract]   [Full Text] [Related]  

  • 31. [The search for new compounds with anticonvulsant action in the 5-benzylidene derivatives of 3-o, 3-m and 3-p-chlorophenylhydantoin].
    Rydzik E; Szadowska A; Kamińska A
    Acta Pol Pharm; 1986; 43(6):572-6. PubMed ID: 3577834
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and anticonvulsant activity of substituted 2-thioquinazolin-4-ones. I. Preliminary studies.
    Glasser AC; Diamond L; Combs G
    J Pharm Sci; 1971 Jan; 60(1):127-9. PubMed ID: 5548222
    [No Abstract]   [Full Text] [Related]  

  • 33. ANTICONVULSANTS. II. SPIRO COMPOUNDS. DIBENZO(A,D)CYCLOHEPTADIENE-5,5'-HYDANTOINS,-5,5'-OXAZOLIDINEDIONES, AND-5,2'-SUCCINIMIDES.
    DAVIS MA; WINTHROP SO; THOMAS RA; HERR F; CHAREST MP; GAUDRY R
    J Med Chem; 1964 Jul; 7():439-45. PubMed ID: 14221121
    [No Abstract]   [Full Text] [Related]  

  • 34. [Synthesis of benzylidene derivatives of 3-o, 3-m and 3-p-chlorophenylhydantoin and the study of their anticonvulsant action].
    Rydzik E; Szadowska A; Kamińska A
    Acta Pol Pharm; 1984; 41(4):459-64. PubMed ID: 6532133
    [No Abstract]   [Full Text] [Related]  

  • 35. Characteristics of the hydrogen bonding interactions of substituted hydantoins with 9-ethyladenine.
    Jones GL; Kemp JW
    Mol Pharmacol; 1974 Jan; 10(1):48-56. PubMed ID: 4152417
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential long-acting anticonvulsants. 1; Synthesis and activity of succinimides containing an alkylating group at the 2 position.
    Kornet MJ; Crider AM; Magarian EO
    J Med Chem; 1977 Mar; 20(3):405-9. PubMed ID: 845873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative structure-activity relationship (QSAR) analysis of the effects of aromatic substitution on the anticonvulsant activity and toxicity of arylsuccinimides.
    Lange J; Kaźmierski W; Daroszewski J
    Pol J Pharmacol Pharm; 1991; 43(1):71-7. PubMed ID: 1771166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and anticonvulsant properties of new 1-(2-pyridinyl)- 3-substituted pyrrolidine-2,5-dione derivatives.
    Kamiński K; Obniska J
    Acta Pol Pharm; 2008; 65(4):457-65. PubMed ID: 19051587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A search for new anticonvulsant compounds among 3-aryl-5-benzylidene derivatives of 2-thiohydantoin.
    Korohoda MJ; Kleinrok Z; Przegaliński E
    Pol J Pharmacol Pharm; 1976; 28(4):329-33. PubMed ID: 981022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific H-bonding of glutarimides and hydantoins to derivatives of RNA bases in chloroform solution.
    Yu NT; Kyogoku Y
    Biochim Biophys Acta; 1973 Nov; 331(1):21-6. PubMed ID: 4148587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.